Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Clinical Trials as Topic"" wg kryterium: Temat


Tytuł :
COVID-19 clinical trials: learning from exceptions in the research chaos.
Autorzy :
Tikkinen KAO; Departments of Urology and Public Health, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.; Department of Surgery, South Karelian Central Hospital, Lappeenranta, Finland.
Malekzadeh R; Digestive Disease Research Institute, Tehran University of Medical Sciences, Tehran, Iran.
Schlegel M; Department of Anesthesiology and Intensive Care, Technical University of Munich School of Medicine, Munich, Germany.
Rutanen J; Department of Internal Medicine, Tampere University Hospital, Tampere, Finland.
Glasziou P; Institute for Evidence-Based Healthcare, Bond University, Robina, Australia. .
Pokaż więcej
Źródło :
Nature medicine [Nat Med] 2020 Nov; Vol. 26 (11), pp. 1671-1672.
Typ publikacji :
Historical Article; Letter
MeSH Terms :
Clinical Trials as Topic*/methods
Clinical Trials as Topic*/organization & administration
Clinical Trials as Topic*/standards
Pandemics*/history
Biomedical Research/*organization & administration
COVID-19/*therapy
Biomedical Research/history ; Biomedical Research/standards ; COVID-19/diagnosis ; COVID-19/epidemiology ; Canada/epidemiology ; Community Networks/organization & administration ; Community Networks/standards ; Drug Evaluation, Preclinical/methods ; Drug Evaluation, Preclinical/standards ; Europe/epidemiology ; History, 21st Century ; Humans ; International Cooperation ; Learning ; Neural Networks, Computer ; Organizational Innovation ; Patient Selection ; Pragmatic Clinical Trials as Topic/methods ; Pragmatic Clinical Trials as Topic/standards ; Research Design ; Scandinavian and Nordic Countries/epidemiology ; United Kingdom/epidemiology ; World Health Organization/organization & administration
Opinia redakcyjna
Tytuł :
Representation of Women in Cardiovascular Clinical Trial Leadership.
Autorzy :
Denby KJ; Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Szpakowski N; Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Silver J; Department of Physical Medicine and Rehabilitation, Massachusetts General Hospital, Boston, Massachusetts.
Walsh MN; Department of Cardiology, St Vincent Hospital, Indianapolis, Indiana.
Nissen S; Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Cho L; Department of Cardiovascular Medicine, Cleveland Clinic Foundation, Cleveland, Ohio.
Pokaż więcej
Źródło :
JAMA internal medicine [JAMA Intern Med] 2020 Oct 01; Vol. 180 (10), pp. 1382-1383.
Typ publikacji :
Journal Article
MeSH Terms :
Leadership*
Cardiologists/*statistics & numerical data
Clinical Trials as Topic/*statistics & numerical data
Physicians, Women/*statistics & numerical data
Cardiovascular Diseases/therapy ; Controlled Clinical Trials as Topic ; Female ; Humans ; Male
Czasopismo naukowe
Tytuł :
RECOVERY 1 year on: a rare success in the COVID-19 clinical trial landscape.
Autorzy :
Mullard A
Pokaż więcej
Źródło :
Nature reviews. Drug discovery [Nat Rev Drug Discov] 2021 May; Vol. 20 (5), pp. 336-337.
Typ publikacji :
Wiadomości
MeSH Terms :
Antiviral Agents*/classification
Antiviral Agents*/pharmacology
Clinical Trials as Topic*/methods
Clinical Trials as Topic*/organization & administration
Clinical Trials as Topic*/standards
COVID-19/*drug therapy
COVID-19/epidemiology ; Clinical Protocols ; Communicable Diseases, Emerging/therapy ; Humans ; Research Design/standards ; SARS-CoV-2 ; Treatment Outcome ; United Kingdom
SCR Protocol :
COVID-19 drug treatment
Periodyk
Tytuł :
The evolution of clinical trials in response to COVID-19.
Autorzy :
Sarah A; University Hospital Geelong, Barwon Health, Geelong, VIC.
Dean O; University Hospital Geelong, Barwon Health, Geelong, VIC.; Institute for Physical and Mental Health and Clinical Translation, Barwon Health, Deakin University, Geelong, VIC.
Berk M; University Hospital Geelong, Barwon Health, Geelong, VIC.; Institute for Physical and Mental Health and Clinical Translation, Barwon Health, Deakin University, Geelong, VIC.
Pokaż więcej
Źródło :
The Medical journal of Australia [Med J Aust] 2021 Apr; Vol. 214 (7), pp. 332-332.e1. Date of Electronic Publication: 2021 Mar 22.
Typ publikacji :
Letter; Research Support, Non-U.S. Gov't
MeSH Terms :
Clinical Trials as Topic*
COVID-19/*prevention & control
COVID-19/*therapy
COVID-19/epidemiology ; COVID-19 Vaccines ; Humans ; Pandemics ; Research Design/trends ; SARS-CoV-2
Raport
Tytuł :
Clinical Trial Outcomes in Urology: Assessing Early Discontinuation, Results Reporting and Publication in ClinicalTrials.Gov Registrations 2007-2019.
Autorzy :
Magnani CJ; School of Medicine, Stanford University, Stanford, California.
Steinberg JR; School of Medicine, Stanford University, Stanford, California.; Department of Obstetrics and Gynecology, Northwestern University, Chicago, Illinois.
Harmange CI; School of Medicine, University of Colorado, Aurora, Colorado.
Zhang X; School of Medicine, Stanford University, Stanford, California.
Driscoll C; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
Bell A; School of Medicine, UCSF, San Francisco, California.
Larson J; Feinberg School of Medicine, Northwestern University, Chicago, Illinois.
You JG; School of Medicine, Stanford University, Stanford, California.
Weeks BT; School of Medicine, Stanford University, Stanford, California.
Hernandez-Boussard T; Department of Medicine, School of Medicine, Stanford University, Stanford CA, USA.
Turner BE; School of Medicine, Stanford University, Stanford, California.; Department of Radiation Oncology, Massachusetts General Hospital, Boston, Massachusetts.
Brooks JD; Department of Urology, Stanford University, Stanford, California.
Pokaż więcej
Źródło :
The Journal of urology [J Urol] 2021 Apr; Vol. 205 (4), pp. 1159-1168. Date of Electronic Publication: 2020 Oct 20.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Clinical Trials as Topic*
Urology*
Databases, Factual ; Humans ; Information Dissemination ; Periodicals as Topic ; Publishing ; Registries ; United States
Czasopismo naukowe
Tytuł :
Clinical and Demographic Factors Influence Clinical Trial Enrollment.
Autorzy :
Suto DJ; Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego CA 619-543-7760, USA. Electronic address: .
Perrinez E; Department of Quality and Patient Safety, University of California San Diego Health, San Diego, CA 619-543-1982 USA. Electronic address: .
Rapp KS; Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego CA 619-543-7760, USA. Electronic address: .
Nabulsi M; Department of Quality and Patient Safety, University of California San Diego Health, San Diego, CA 619-543-1982 USA. Electronic address: .
Hemmen TM; Department of Neurosciences, University of California San Diego, 200 W. Arbor Drive, San Diego CA 619-543-7760, USA. Electronic address: .
Pokaż więcej
Źródło :
Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association [J Stroke Cerebrovasc Dis] 2021 Jun; Vol. 30 (6), pp. 105771. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Eligibility Determination*
Patient Selection*
Ischemic Stroke/*diagnosis
Ischemic Stroke/*epidemiology
Age Factors ; Aged ; Bias ; Comorbidity ; Databases, Factual ; Female ; Health Status ; Humans ; Ischemic Stroke/therapy ; Male ; Middle Aged ; Race Factors ; Risk Factors ; Social Determinants of Health ; Socioeconomic Factors
Czasopismo naukowe
Tytuł :
COVID-19 and the Emerging Regulatory Guidance for Ongoing Clinical Trials in the European Union.
Autorzy :
de Jong AJ; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Santa-Ana-Tellez Y; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
van Thiel GJMW; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Zuidgeest MGP; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
Siiskonen SJ; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Mistry D; Covance Clinical Services Ltd, Maidenhead, UK.
de Boer A; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.; Dutch Medicines Evaluation Board, Utrecht, The Netherlands.
Gardarsdottir H; Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Pokaż więcej
Corporate Authors :
Trials@Home Consortium
Źródło :
Clinical pharmacology and therapeutics [Clin Pharmacol Ther] 2021 Jun; Vol. 109 (6), pp. 1517-1527. Date of Electronic Publication: 2021 Apr 02.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
COVID-19/*drug therapy
COVID-19/*epidemiology
Clinical Trials as Topic/*organization & administration
Drug Approval/*organization & administration
European Union/*organization & administration
Clinical Trials as Topic/standards ; Decision Making ; Humans ; Medication Adherence ; Pandemics ; Research Design ; SARS-CoV-2 ; Telemedicine ; Time Factors
Czasopismo naukowe
Tytuł :
COVID-19 vaccine guidance for patients with cancer participating in oncology clinical trials.
Autorzy :
Desai A; Division of Medical Oncology, Mayo Clinic College of Medicine, Rochester, MN, USA.
Gainor JF; Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
Hegde A; Department of Hematology and Oncology, O'Neal Comprehensive Cancer Center, University of Alabama at Birmingham, Birmingham, AL, USA.
Schram AM; Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Curigliano G; Department of Oncology and Hemato-Oncology, University of Milan and European Institute of Oncology, IRCCS, Milan, Italy.
Pal S; Department of Medical Oncology, City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
Liu SV; Department of Developmental Therapeutics, Lombardi Comprehensive Cancer Center, Georgetown University, Washington, DC, USA.
Halmos B; Department of Oncology, Montefiore Medical Center, Albert Einstein College of Medicine, The Bronx, NY, USA.
Groisberg R; Department of Melanoma/Sarcoma Medical Oncology, Rutgers Cancer Institute of New Jersey, New Brunswick, NJ, USA.
Grande E; Department of Medical Oncology, MD Anderson Cancer Center Madrid, Madrid, Spain.
Dragovich T; Department of Hematology/Oncology, MD Anderson Banner Cancer Center, Gilbert, AZ, USA.
Matrana M; Precision Cancer Therapies (Phase I) Research Program, Experimental Therapeutics, Ochsner, New Orleans, LA, USA.
Agarwal N; Division of Oncology, Department of Medicine, Huntsman Cancer Institute, University of Utah, Salt Lake City, UT, USA.
Chawla S; Sarcoma Oncology Center, Santa Monia, CA, USA.
Kato S; Center for Personalized Cancer Therapy, Moores Cancer Center, University of California San Diego, La Jolla, CA, USA.
Morgan G; Department of Oncology, Skåne University Hospital, Lund, Sweden.
Kasi PM; Division of Hematology, Oncology and Blood and Marrow Transplantation, Department of Medicine, University of Iowa, Iowa City, IA, USA.
Solomon B; Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Victoria, Australia.
Loong HH; Department of Clinical Oncology, State Key Laboratory of Translational Oncology, The Chinese University of Hong Kong, Hong Kong SAR, China.
Park H; Division of Oncology, Department of Medicine, Washington University in St. Louis, St Louis, MO, USA.
Choueiri TK; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Subbiah IM; Department of Palliative, Rehabilitation & Integrative Medicine, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Pemmaraju N; Department of Leukemia, Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA.
Subbiah V; Department of Investigational Cancer Therapeutics (Phase I Clinical Trials Program), Division of Cancer Medicine, University of Texas MD Anderson Cancer Center, Houston, TX, USA. .; Division of Pediatrics, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .; MD Anderson Cancer Network, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. .
Pokaż więcej
Corporate Authors :
COVID19 and Cancer Clinical Trials Working Group
Źródło :
Nature reviews. Clinical oncology [Nat Rev Clin Oncol] 2021 May; Vol. 18 (5), pp. 313-319. Date of Electronic Publication: 2021 Mar 15.
Typ publikacji :
Journal Article; Practice Guideline; Research Support, N.I.H., Extramural; Review
MeSH Terms :
Clinical Trials as Topic*
Neoplasms*/therapy
COVID-19/*prevention & control
COVID-19 Vaccines/*therapeutic use
Vaccination/*standards
Humans ; Patient Selection ; SARS-CoV-2
Czasopismo naukowe
Tytuł :
Discovering treatment effectiveness via median treatment effects-Applications to COVID-19 clinical trials.
Autorzy :
Mullahy J; Department of Population Health Sciences, University of Wisconsin-Madison, Madison, Wisconsin, USA.; National Bureau of Economic Research, Cambridge, Massachusetts, USA.; NUI Galway, Health Economics and Policy Analysis Centre, Galway, Ireland.
Pokaż więcej
Źródło :
Health economics [Health Econ] 2021 May; Vol. 30 (5), pp. 1050-1069. Date of Electronic Publication: 2021 Mar 05.
Typ publikacji :
Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Clinical Trials as Topic*
Decision Making*
Treatment Outcome*
COVID-19/*therapy
Humans
Czasopismo naukowe
Tytuł :
COVID-19 and cancer: A clear change not only in daily clinical practice but also in clinical research management.
Autorzy :
Giuliani J; Department of Oncology, Mater Salutis Hospital, Legnago (VR), Italy.
Bonetti A; Department of Oncology, Mater Salutis Hospital, Legnago (VR), Italy.
Pokaż więcej
Źródło :
Journal of medical virology [J Med Virol] 2021 May; Vol. 93 (5), pp. 2564-2565. Date of Electronic Publication: 2020 Dec 01.
Typ publikacji :
Letter
MeSH Terms :
COVID-19/*epidemiology
Clinical Trials as Topic/*organization & administration
Neoplasms/*therapy
COVID-19/prevention & control ; Clinical Trials as Topic/statistics & numerical data ; Health Services Accessibility/organization & administration ; Health Services Accessibility/statistics & numerical data ; Humans ; Neoplasms/epidemiology ; Palliative Care/organization & administration ; Palliative Care/statistics & numerical data ; SARS-CoV-2
Opinia redakcyjna
Tytuł :
Regulatory approval of COVID-19 vaccine for restricted use in clinical trial mode.
Autorzy :
Mohapatra PR; All India Institute of Medical Sciences, Bhubaneswar 751019, India. Electronic address: .
Mishra B; All India Institute of Medical Sciences, Bhubaneswar 751019, India.
Pokaż więcej
Źródło :
The Lancet. Infectious diseases [Lancet Infect Dis] 2021 May; Vol. 21 (5), pp. 599-600. Date of Electronic Publication: 2021 Jan 25.
Typ publikacji :
Letter
MeSH Terms :
COVID-19 Vaccines*
Clinical Trials as Topic*
COVID-19/*prevention & control
SARS-CoV-2/*immunology
Drug Approval ; Humans
Opinia redakcyjna
Tytuł :
Creatine Supplementation for Patients with Inflammatory Bowl Diseases: A Scientific Rationale for a Clinical Trial.
Autorzy :
Wallimann T; Department of Biology, ETH-Zurich, Emeritus, 8962 Bergdietikon, Switzerland.
Hall CHT; Mucosal Inflammation Program and Department of Pediatrics, Division of Gastroenterology, Hepatology and Nutrition, Children's Hospital Colorado, University of Colorado, 12700 E. 19th Ave, Aurora, CO 80045, USA.
Colgan SP; Mucosal Inflammation Program and Department of Medicine, Division of Gastroenterology and Hepatology, University of Colorado, 12700 E 19th Ave, Aurora, CO 80045, USA.
Glover LE; Comparative Immunology Group, School of Biochemistry and Immunology, Trinity Biomedical Sciences Institute, Trinity College Dublin, D2 Dublin, Ireland.
Pokaż więcej
Źródło :
Nutrients [Nutrients] 2021 Apr 23; Vol. 13 (5). Date of Electronic Publication: 2021 Apr 23.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Clinical Trials as Topic*
Dietary Supplements*
Creatine/*therapeutic use
Inflammatory Bowel Diseases/*drug therapy
Creatine/pharmacology ; Endpoint Determination ; Humans ; Intestines/drug effects ; Intestines/pathology
Czasopismo naukowe
Tytuł :
The UPTAKE study: implications for the future of COVID-19 vaccination trial recruitment in UK and beyond.
Autorzy :
Sethi S; The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, UK. .
Kumar A; The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, UK.
Mandal A; University of Birmingham, Birmingham, UK.
Shaikh M; National Institute for Health Research, Clinical Research Network, Coventry, West Midlands, UK.
Hall CA; National Institute for Health Research, Clinical Research Network, Coventry, West Midlands, UK.
Kirk JMW; National Institute for Health Research, Clinical Research Network, Coventry, West Midlands, UK.; Research Institute in Healthcare Sciences (RIHS), University of Wolverhampton, Wolverhampton, UK.
Moss P; University of Birmingham, Birmingham, UK.
Brookes MJ; The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, UK.; National Institute for Health Research, Clinical Research Network, Coventry, West Midlands, UK.; Research Institute in Healthcare Sciences (RIHS), University of Wolverhampton, Wolverhampton, UK.
Basu S; The Royal Wolverhampton NHS Trust, New Cross Hospital, Wolverhampton Road, Wolverhampton, West Midlands, WV10 0QP, UK.; National Institute for Health Research, Clinical Research Network, Coventry, West Midlands, UK.; Research Institute in Healthcare Sciences (RIHS), University of Wolverhampton, Wolverhampton, UK.
Pokaż więcej
Źródło :
Trials [Trials] 2021 Apr 20; Vol. 22 (1), pp. 296. Date of Electronic Publication: 2021 Apr 20.
Typ publikacji :
Journal Article
MeSH Terms :
Clinical Trials as Topic*
Patient Selection*
COVID-19/*prevention & control
COVID-19 Vaccines/*administration & dosage
Adolescent ; Adult ; Aged ; Cross-Sectional Studies ; Female ; Humans ; Male ; Middle Aged ; Pandemics ; Surveys and Questionnaires ; United Kingdom ; Vaccination ; Young Adult
Czasopismo naukowe
Tytuł :
Vegetable Extracts and Nutrients Useful in the Recovery from Helicobacter pylori Infection: A Systematic Review on Clinical Trials.
Autorzy :
Ullah H; Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.
Di Minno A; Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.; CEINGE-Biotecnologie Avanzate, 80131 Naples, Italy.
Santarcangelo C; Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.
Khan H; Department of Pharmacy, Abdul Wali Khan University, Mardan 23200, Pakistan.
Xiao J; International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, China.
Arciola CR; Department of Experimental, Diagnostic and Specially Medicine, University of Bologna, via San Giacomo 14, 40126 Bologna, Italy.; Laboratorio di Patologia delle Infezioni Associate all'Impianto, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy.
Daglia M; Department of Pharmacy, University of Naples Federico II, 80131 Naples, Italy.; International Research Center for Food Nutrition and Safety, Jiangsu University, Zhenjiang 212013, China.
Pokaż więcej
Źródło :
Molecules (Basel, Switzerland) [Molecules] 2021 Apr 14; Vol. 26 (8). Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article; Systematic Review
MeSH Terms :
Clinical Trials as Topic*
Nutrients*
Helicobacter Infections/*microbiology
Helicobacter pylori/*physiology
Plant Extracts/*pharmacology
Vegetables/*chemistry
Helicobacter pylori/drug effects ; Humans
Czasopismo naukowe
Tytuł :
Conducting clinical trials during the COVID-19 pandemic-a collaborative trial network response.
Autorzy :
Robison L; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia. .
Cho Y; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.; The Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Viecelli AK; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.; The Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.
Johnson DW; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.; The Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.; The Translational Research Institute, Brisbane, QLD, Australia.
Hawley CM; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.; The Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.; The Translational Research Institute, Brisbane, QLD, Australia.
Valks A; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
Paul-Brent PA; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
Stastny R; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
Varghese J; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
Kiriwandeniya C; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
Pascoe EM; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
Vergara LA; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
Fahim MA; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.; The Department of Nephrology, Princess Alexandra Hospital, Brisbane, QLD, Australia.; Metro North Hospital & Health Service, Brisbane, QLD, Australia.
Boudville N; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.; The Medical School, University of Western Australia, Perth, WA, Australia.
Krishnasamy R; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.; Department of Nephrology, Sunshine Coast University Hospital, Birtinya, QLD, Australia.
Reidlinger D; Australasian Kidney Trials Network, The University of Queensland, Level 5, Translational Research Institute, 37 Kent Street, Woolloongabba, QLD, 4102, Australia.
Pokaż więcej
Corporate Authors :
Australasian Kidney Trials Network
Źródło :
Trials [Trials] 2021 Apr 14; Vol. 22 (1), pp. 278. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Letter
MeSH Terms :
COVID-19*
Clinical Trials as Topic*
Pandemics*
Australasia ; Humans ; Research Personnel
Opinia redakcyjna
Tytuł :
Monitoring advances including consent: learning from COVID-19 trials and other trials running in UKCRC registered clinical trials units during the pandemic.
Autorzy :
Love SB; MRC Clinical Trials Unit at UCL, 90 High Holborn, WC1V 6LJ, London, UK. .
Armstrong E; Clinical Trials Research Unit, Leeds Institute of Clinical Trials Research, University of Leeds, Leeds, LS2 9JT, UK.
Bayliss C; Cambridge Clinical Trials Unit, Coton House Level 6, Cambridge University Hospitals NHS Foundation Trust, Addenbrooke's Hospital, Hills Road, Cambridge, CB2 0QQ, UK.
Boulter M; Nottingham Clinical Trials Unit, Building 42, University Park, Nottingham, NG7 2RD, UK.
Fox L; The Institute of Cancer Research - Clinical Trials and Statistics Unit, The Institute of Cancer Research, London, SM2 5NG, UK.
Grumett J; Warwick Clinical Trials Unit, Warwick Medical School, University of Warwick, Coventry, CV4 7AL, UK.
Rafferty P; Northern Ireland Clinical Trials Unit, Elliot Dynes Building, Royal Hospitals, Belfast, BT12 6BA, UK.
Temesi B; Manchester Clinical Trials Unit, The University of Manchester, Jean McFarlane Building, Oxford Road, Manchester, M13 9PL, UK.
Wills K; Cancer Research UK & UCL Cancer Trials Centre, UCL, 90 Tottenham Court Road, London, W1T 4TJ, UK.
Corkhill A; Southampton Clinical Trials Unit, University of Southampton, MP131, Southampton General Hospital, Tremona Road, Southampton, SO16 6YD, UK.
Pokaż więcej
Źródło :
Trials [Trials] 2021 Apr 14; Vol. 22 (1), pp. 279. Date of Electronic Publication: 2021 Apr 14.
Typ publikacji :
Journal Article
MeSH Terms :
COVID-19*
Clinical Trials as Topic*
Informed Consent*
Humans ; Pandemics ; United Kingdom
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies